RxDoctor Payments Data

Thomas Gildea, MD

Pulmonary Disease · Cleveland, OHNPI 1164485959

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (28.3%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Intuitive Surgical at 37.1% of the total. Reporting peaked in 2022 at $19,046 and has fallen 91.8% since, to $1,565 in 2025. Among pulmonary disease clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,727in general payments, 2019–2025

Across 189 payments — averaging $363.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$25K
  • Siemens Medical Solutions USA, Inc.$12K
  • Medtronic$8K
  • Cook Incorporated$8K
  • Johnson & Johnson$8K
  • Verathon Inc.$2K
  • plus $5K from 18 others
$85,830in research payments, 2019–2025

Across 20 payments — averaging $4291.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Johnson & Johnson$41K
  • Auris Health, Inc.$17K
  • Medtronic$16K
  • Ethicon Endo-surgery Inc.$12K

What the payments were for

  • Consulting fees$18,72627%
  • Speaking & faculty fees$18,67527%
  • Travel & lodging$19,46428%
  • Food & beverage$5,8629%
  • Education$6,0009%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,727 in reported general payments places this provider in the 95th percentile of 571 pulmonary disease providers in Ohio.

See all pulmonary disease providers in Ohio

Medicare billing

Part B allowed, 2024
$33,270
Medicare patients
134
Services billed
326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azithromycin13$134

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →